Buffett described how share prices do not reflect business value, discussing the role of TSR and dividends in the context of Royalty Pharma.

2 reports, 0 independent Updated Jun 29

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Buffett described how share prices do not reflect business value, discussing the role of TSR and dividends in the context of Royalty Pharma.

Who's involved

What this event is mainly about

Warren Buffett Royalty Pharma TSR

Keep exploring

Part of

Warren Buffett discussed the difference between share price and business value, alongside the role of TSR in total shareholder return. All 2 developments

The entities involved

Warren Buffett
American investor, entrepreneur and businessman
- Bill Ackman, head of Pershing Square, stated that his investment ethos aligns with the principles of Ben Graham and Warren Buffett.Fri 18:11
- Warren Buffett's investment approach is cited in relation to Mirae Asset.Fri 10:29
Royalty Pharma
biopharmaceutical company based in New York City
- Royalty Pharma acquired a royalty interest in Amgen's drug Imdelltra.Sat 18:11
- Royalty Pharma is investing in drug makers and developers to diversify its portfolio in the biotech sector.Sun 15:42
TSR
former company, publisher of Dungeons & Dragons

Nothing else this week.

Related events

Warren Buffett concentrates his investments within the Berkshire Hathaway conglomerate.Sep 5

Coverage

Newest first; wire copies grouped

Jun 29Unknown outlet
Jun 22Unknown outlet